Abstract
Introduction
Chemo-radiation therapy (CRT) is the standard of care for locally advanced cervical cancer and improves local control and survival [1] . The role of advanced imaging is steadily increasing in the management of gynecological malignancies, both for treatment planning and response monitoring [2] [3] [4] [5] [6] [7] [8] [9] [10] . Magnetic resonance imaging (MRI) and positron emission tomography (PET) play a pivotal role in planning and monitoring the response to CRT [2] [3] [4] [5] [6] [11] [12] [13] [14] . MRI provides morphological and functional information on tumor neo-angiogenesis, perfusion, and tissue cellularity, using multiple parameters, such as T2-weighted, contrast-enhanced (CE), and diffusion-weighted imaging (DWI) [15] [16] [17] [18] [19] [20] [21] [22] . PET, using the radiotracer 2-deoxy-2- tumor activity [13, 14] . In locally advanced cervical cancer, it is known for a long time that tumor hypoxia is associated with increased resistance to CRT, thus diminishing the rate of local control as well as distant disease control [23] [24] [25] [26] [27] [28] [29] [30] . Traditional clinical methods to determine hypoxic regions are invasive and based on needle electrodes or tissue sampling [23, 27, 28, 31] . PET imaging using [ Therefore it might be of considerable additional value for improved planning and monitoring of CRT for cervix cancer [23-28, 32, 33] . To date, the potential of PET/MRI for locally advanced cervical cancer, using multiple MRI parameters and different radiotracers in the assessment of cervical cancer, has not been explored.
We hypothesized that through the non-invasive quantitative assessment of multiple processes relevant for cancer growth, progression and aggressiveness (tumor neo-angiogenesis and perfusion, cellularity, glycolytic metabolic activity, tumor hypoxia) [34] hitherto unparalleled insights into tumor biology on multiple levels could be provided by multiparametric (MP) [ 
F]FDG/ [
18 F]FMISO PET/MRI, which can be subsequently used for treatment stratification and intensification. The aim of this study was to explore MP MRI and PET in patients with locally advanced cervix cancer. Thus, the aim of our study was to assess whether fused MP [ PET/MRI in cervical cancer patients is possible and facilitates information on tumor heterogeneity, which might improve the planning of CRT. To reach this goal, we used multiple MRI parameters (high-resolution T2-weighted-, CE-MRI, DWI) and the combination of these parameters with the radiotracers [ 
Materials and Methods

Patients
From 05/2012 to 07/2014, sixteen consecutive patients (mean age, 51.8; range, , who presented at the Department of Radiation Oncology for treatment, were included in this prospective, single-institution feasibility study, which was approved by the institutional review board (IRB)/ Ethics Committee of the Medical University of Vienna, Austria. All patients fulfilled the following inclusion criteria and underwent dual tracer MP PET/MRI: 18 years or older; histopathologically verified locally advanced cervical cancer scheduled for treatment with CRT; not pregnant; not breastfeeding; no previous treatment; and no contraindications for MRI or contrast agents. Written, informed consent was obtained from all patients. Examinations of 11 patients were completed within a median of one week (range 2-23) and were used for this study. The remaining patients did either not want to complete the study or treatment could not be delayed for the imaging study.
Imaging
Prior to commencement of treatment all patients underwent fused PET/MRI with PET/computed tomography (CT), using as low-dose scans. The same imaging and post-recon parameters were used for both PET/CT studies. PET images were reconstructed using the iterative TrueX algorithm, which incorporates a specific correction for the point-spread function in addition to commonly used correction factors [35, 36] . Four iterations per 21 subsets were used, with a matrix size of 168×168, a trans-axial field of view of 605 mm (pixel size 3.6mm), and a section thickness of 5mm. Further technical details are provided by the manufacturer [37] . MP MR Imaging. All MRI studies were performed with the patient in the supine position using a 3T MRI (Tim-Trio, Siemens, Erlangen/Germany). A combination of an eight-channel spine array (24 elements in eight clusters) and a two-channel body array (six elements in two clusters) was used for signal acquisition. The MRI protocol consisted of: , Guerbet, France) was injected intravenously as a bolus (0.1mmol/kg body weight) using a power injector at 4 ml/s, followed by a 20mL saline flush. The total MRI examination time was~16min.
Image Fusion
Rigid registrations for descriptive statistics. For descriptive statistics, the images were analyzed and registered using Mirada RTx software (Mirada Medical Ltd., UK). Datasets acquired on the same scanners, i.e. PET/CT and MP MRI data, were initially fused according to DICOM tag information. The correlation of the anatomy on respective modalities was visually checked by the readers in consensus and adjusted if necessary utilizing the available software options (automatic, mutual information-based, and manual rigid registration). To achieve optimal registration fusion of [
18 F]FDG, [ 18 F]FMISO, and MP MRI the registration was performed in two steps (visualized as arrows in Fig 1) . First, the CT series of the respective PET-CT examinations were registered and the two PET series were saved in the same coordinate system. Subsequently, the registration between PET and MP MRI datasets was performed using CT and anatomic T2-weighted MR images. In both steps, the automatic and manual rigid registration tools were used with a special focus on the cervix. Deformable image registrations for voxel-by-voxel analysis. For voxel-by-voxel analysis deformable image registration (DIR) was applied. In this step the uterus, cervix as well as the different helper structures were defined on CT and projected onto
PET/CT and axial T1-weighted MRI data. All images were resampled to the voxel size of 0.6 x 0.6 x 3mm 3 . Hybrid-, intensity-, and structure-based DIR were performed for MP MRI and The uterus was used as the controlling structure and helper structures were used as focus structures to limit the registration calculations to this region.
Data analysis
An experienced radiologist and an experienced nuclear medicine physician in consensus prospectively evaluated MP [ High-resolution T2-weighted and CE-MRI. CE-MRI imaging data was assessed for tumor morphology, and for initial and delayed enhancement kinetics. For analysis of lesion enhancement kinetics in the early (1min) and delayed phase (5min), manually drawn region-of interests (ROI) were placed in the most enhancing parts of a lesion and the intensity courses were plotted against time. Initial enhancement (IE) was defined as either medium (<1.5) or fast (>1.5), and enhancement in the delayed phase was defined as either wash-out (<-0.1), plateau (>-0.1 and <0.1), or persistent (>0.1). The lower the rate the faster the wash-out (WO). Lesion volume in cc was calculated by measuring the largest diameter of the tumor in all three planes on the CE-MRI.
DWI. High-b-value DW images (i.e., 850s/mm 2 ) were visually assessed for hyperintense areas that corresponded to the morphologically visible tumor on T2-weighted and CE-MRI. Two-dimensional ROIs were manually drawn covering the area, visually assessed, with the lowest ADC values inside the lesion, and the mean ADC was recorded. Partial volume effects due to normal parenchyma, suppressed fatty tissue, and areas of necrotic tissue, as identified from the morphological and contrast-enhanced images, were avoided as far as possible.
[ 
Voxel-by-voxel analysis
The voxel-by-voxel analysis of all MRI and PET parameters on the delineated cervix was performed using an in-house-developed MATLAB script. Due to the lower image resolution of Step-by-step illustration of the rigid registration algorithm. PET images and ADC maps, and to compensate for potential inaccuracies of registration between the imaging modalities, a slice-wise sliding window of 24 pixels surrounding the pixel of interest (middle pixel) was used to calculate the average of the measured parameters in this area. Values between the 0.5 th and 99.5 th percentiles were taken into consideration. Tumor-tobackground ratio maps for PET, as well as initial and delayed enhancement maps for CE-MRI, were calculated. Fig 2 illustrates representative voxel-by-voxel correlations between pairs of PET/MRI dataset-derived parameters. Statistical analysis. Statistical analyses were performed using Statistical Package for the Social Sciences (IBM SPSS Statistics 22.0). Correlations between items were investigated by constructing a color-coded nonparametric Spearman's rank correlation coefficient matrix. Pvalues <0.05 were considered significant (a two-tailed significance test was used). Correlations of voxel-by-voxel analysis between the imaging parameters were assessed with the nonparametric Spearman's rank correlation coefficient and by plotting a set of 10 scatter plots for each patient, which combined each pair of investigated parameters. In PET datasets, only voxels with a tumor-to-background ratio higher than 2, for [ were taken into account. For all parameter pairs, the average correlation coefficients that resulted from the patient-wise analysis were calculated using Fisher Z-transformation, and a color-coded correlation coefficient matrix was plotted.
Results
Image registration between the various MRI sequences and PET image series was successfully performed in all eleven patients with complete data sets. There was a fast initial enhancement (IE) in five and a medium IE in six patients, followed by either a wash-out (n = 6), a plateau (n = 3), or persistent (n = 2) enhancement. 
Lesion-based descriptive statistics
Correlations between tumor volume, various MRI and PET parameters are summarized in Fig 3. A statistically significant strong direct correlation was found for [ 18 
Voxel-by-voxel analysis
A voxel-by-voxel analysis of MP MRI and PET information was successfully performed in eight patients. In three patients DIR was not satisfactory due to either location of the tumor (n = 2) and too poor quality of the low-dose attenuation correction CT for [ 18 F]FMISO. Fig 4 summarizes the respective correlations between MRI and PET parameters for these eight patients. Except for initial and delayed enhancement, which showed a significant strong indirect correlation, i.e. tumors that show fast initial enhancement present with a wash-out, all other correlation of MRI and PET parameters were weak, ranging from 0.05-0. 22 insights into tumor biology on multiple levels. This technique also provides information on tumor heterogeneity that in the future can be used for personalized cancer treatment by introducing dose-painting concepts with inhomogeneous radiation dose prescription and/or intensified chemotherapy regimens [2] [3] [4] [5] [6] 11] . Functional imaging with MP MRI is now part of the standard imaging protocol for treatment planning and prognostication for locally advanced cervical cancer [2] [3] [4] [5] [6] [11] [12] [13] [14] . CE-MRI provides high-resolution anatomic information, depicts neo-angiogenesis, and quantifies the extent of poorly perfused regions within cervical tumors [3, 15, 17, 18, 43] . Poorly perfused tumor regions have been found to be an independent predictor of recurrence and survival [16] [17] [18] [19] [20] 44] . DWI provides information about tissue cellularity, which is an important factor in tumor response to CRT [22] . In addition, DWI has been identified as an imaging biomarker in cervical cancer for the early monitoring of response to CRT [22, 45] . Nevertheless, valuable information on metabolic and hypoxic tumor sub-volumes, which is pivotal for treatment planning, especially with regard to dose-painting with CRT, is limited with MRI alone. [5, 6] , while avoiding irradiation of normal tissue. [ 18 F]FDG PET facilitates the longitudinal tracking of metabolic disease during CRT, and the respective metabolic response to CRT is predictive of long-term survival [4, 5] . Tumor hypoxia is associated with increased resistance to ionizing radiation and various types of chemotherapy, thus diminishing the rate of local control as well as distant disease control [23] [24] [25] [26] [27] [28] . Previous methods to measure and track tumor hypoxia comprised solely invasive assessment with needle electrodes or biopsy [23, 27, 28, 31] FMISO PET/MRI has the potential to have a significant impact on cervical cancer treatment as a surrogate marker of CRT efficacy and drug activity at the tumor microenvironment level. Nevertheless, this study has some limitations. The patient collective is small. More patients agreed to participate than actually completed this study. Multimodality imaging studies are demanding for the patients, especially if performed on two scanners. This was the main reason why about 30% of the patient did not complete it. Performing such comprehensive imaging with simultaneous PET/MRI scanners, which are currently being installed world-wide, will certainly increase patient compliance [50] . Furthermore, simultaneous PET/MRI will overcome the other limitation of this study with respect to image post-processing for data correlation. Loosing valuable patient information like in this study, where for three patients a voxel-byvoxel analysis could not be performed, will also be avoided. Larger-scale studies, as well as consecutive examination during CRT, will be needed and are currently on-going to corroborate these results and to fully elucidate the predictive and prognostic potential of Supporting Information 
